Roivant
ROIV
Performance
About Roivant
Roivant is a biotech and healthcare technology company that builds nimble, entrepreneurial companies called Vants to accelerate discovery, development, and commercialization of medicines. The group emphasizes sourcing talent, aligning incentives, and deploying technology across its portfolio to move medicines faster to patients. With a global footprint including offices in New York and Basel, Roivant operates through diverse companies focused on transformative therapies and related technologies.
Recent News
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Roivant Spinout Priovant Touts Phase 2 Brepocitinib Data in Cutaneous Sarcoidosis
Proxima Raises $80M in Seed Funding
STAT+: Roivant Immune Drug Significantly Outperformed Placebo in Treating Rare Skin Disease
VantAI Gets $80M and New Name; Dynavax Discloses It Had Pre-Sanofi Suitor
Recent Deals
No recent deals for this company.